Avenue Therapeutics ATXI
OTC ATXI
$0.38 -0.03 (-8.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Avenue Therapeutics (ATXI) Short-term Investments (2017 - 2019)

Updated

Avenue Therapeutics' Short-term Investments came in at $5 million for Q3 2019, unchanged from the prior quarter.

Analysis

Avenue Therapeutics (ATXI) Short-term Investments (2017 - 2019) Analysis & Trends

At the end of FY2017, Avenue Therapeutics' Short-term Investments was $10 million.

  • The five-year range for quarterly Short-term Investments is $5 million (Q2 2019) to $10 million (Q4 2017).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Avenue Therapeutics 1.32 Mn -9.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 5.00 Mn
Jun 30, 2019 5.00 Mn
Dec 31, 2017 10.00 Mn
Sep 30, 2017 10.00 Mn
API Access

Avenue Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=ATXI&period=max&api_key=YOUR_API_KEY